faCellitate

Mannheim, Germany

faCellitate is a life science tools company targeting customers in drug discovery, toxicology, industrial biotech and stem cell research.

$3.7M raised

Sep 2022

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has faCellitate raised?

faCellitate has raised $3.7M in total funding. The most recent round was Seed. The last funding was announced in September 2022.

Who are faCellitate's investors?

faCellitate's investors include HTGF (High-Tech Gruenderfonds), R3, Arve Capital, Chemovator, SARSTEDT.

Where is faCellitate headquartered?

faCellitate is headquartered in Mannheim, Germany.

What does faCellitate do?

faCellitate is a life science tools company targeting customers in drug discovery, toxicology, industrial biotech and stem cell research.

What stage is faCellitate at?

faCellitate is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 7, 2022.

MLA

"faCellitate — Funding & Investors." VCBacked, September 7, 2022, https://www.vcbacked.co/company/facellitate. Accessed July 2, 2026.

APA

VCBacked. (2022). faCellitate — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/facellitate

Wikipedia (cite web)

{{cite web |title=faCellitate — Funding & Investors |url=https://www.vcbacked.co/company/facellitate |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 7, 2022.